# Piedmont Reproductive Endocrinology Group, Pa – FDA Inspection, Jan 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/piedmont-reproductive-endocrinology-group-pa/20389128-90c1-49f2-a420-f61b3f0997e6
Source feed: FDA_Inspections

> FDA inspection 1300792 of Piedmont Reproductive Endocrinology Group, Pa, January 21, 2026. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1300792
- Company Name: Piedmont Reproductive Endocrinology Group, Pa
- Inspection Date: 2026-01-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Atlanta District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1193365 - 2022-12-06
- FDA Inspection 1122803 - 2020-01-28
- FDA Inspection 1040306 - 2018-01-31
- FDA Inspection 966721 - 2016-04-19
- FDA Inspection 876598 - 2014-04-29

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/richard-j-bashay/ce50702d-1f5b-42c5-b50a-88bb43cba196)

Company: https://www.keypedia.com/companies/piedmont-reproductive-endocrinology-group-pa/b2ee7cdb-2340-42b8-9f2d-d3e318b64d0b

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7
